Grant: Research Tools and Instruments - Category 1 (<$150,000)
McMaster University
$95,968.00
Assaying the performance of "smart" drug delivery vehicles using high-performance liquid chromatography
EF 2009-10
Résumé
Modern pharmaceuticals have revolutionized our ability to treat or cure most major diseases. Typically, drug treatments require repeated oral, nasal, or injection-based treatments, ultimately leading to transport of the drug into the bloodstream to be distributed throughout the body. However, such systemic drug treatments can lead to significant side-effects and require repeat administrations which are inconvenient and often uncomfortable for the patient. As a result, polymer-based drug delivery devices which can release controlled doses of drugs at both the rate and location required in the body would lead to significantly improved clinical outcomes in the treatment of many diseases. The co-applicants are all actively involved in developing novel drug delivery systems which would meet these requirements. Materials including hydrogels which will spontaneously form when injected into the body to control drug release, new types of biodegradable microparticles and nanoparticles which can overcome many of the current issues with loading and stabilizing large concentrations of sensitive drugs, bioactive paper which can bind, detect, or release drugs, and composite hydrogel-nanoparticle materials which can be remotely triggered to deliver new types of pharmaceutical targets with adjustable, repeatable doses are all under development within the labs of the co-applicants. These materials are currently being applied for developing new ophthalmic, intramuscular, or intravenous drug delivery vehicles which can deliver a full spectrum of target drugs over durations ranging from several hours to several months. Integral to successful development of such materials is the availability of a method to measure the amount of drug which can be encapsulated inside these new materials and subsequently released over time. In this context, access to a high performance liquid chromatograph (HPLC) is urgently needed to make accurate, high-sensitivity measurements of the drug doses released from these new materials and thus assess the potential of such materials for meeting existing drug delivery challenges.
Programme
Research Tools and Instruments - Category 1 (<$150,000)
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
389931-2010
Name nom
Hoare, Todd
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2009
Competition year année de concours
2010
Award amount
95968
Program id
EQPEQ
Program nane en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1511
Committee name en
Materials and Chemical Engineering
Committee name fr
Génie chimique et des matériaux
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
1800
Research subject group en
Chemical engineering
Research subject group fr
Génie chimique
Research subject en
Chemical engineering
Research subject fr
Génie chimique
Partie
1
Nb partie
1
Application title
Assaying the performance of "smart" drug delivery vehicles using high-performance liquid chromatography
Keyword
NA
Application summary
Modern pharmaceuticals have revolutionized our ability to treat or cure most major diseases. Typically, drug treatments require repeated oral, nasal, or injection-based treatments, ultimately leading to transport of the drug into the bloodstream to be distributed throughout the body. However, such systemic drug treatments can lead to significant side-effects and require repeat administrations which are inconvenient and often uncomfortable for the patient. As a result, polymer-based drug delivery devices which can release controlled doses of drugs at both the rate and location required in the body would lead to significantly improved clinical outcomes in the treatment of many diseases. The co-applicants are all actively involved in developing novel drug delivery systems which would meet these requirements. Materials including hydrogels which will spontaneously form when injected into the body to control drug release, new types of biodegradable microparticles and nanoparticles which can overcome many of the current issues with loading and stabilizing large concentrations of sensitive drugs, bioactive paper which can bind, detect, or release drugs, and composite hydrogel-nanoparticle materials which can be remotely triggered to deliver new types of pharmaceutical targets with adjustable, repeatable doses are all under development within the labs of the co-applicants. These materials are currently being applied for developing new ophthalmic, intramuscular, or intravenous drug delivery vehicles which can deliver a full spectrum of target drugs over durations ranging from several hours to several months. Integral to successful development of such materials is the availability of a method to measure the amount of drug which can be encapsulated inside these new materials and subsequently released over time. In this context, access to a high performance liquid chromatograph (HPLC) is urgently needed to make accurate, high-sensitivity measurements of the drug doses released from these new materials and thus assess the potential of such materials for meeting existing drug delivery challenges.